Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Leo Rasche(University of Arkansas for Medical Sciences), Shweta S. Chavan(University of Arkansas for Medical Sciences), Owen Stephens(University of Arkansas for Medical Sciences), Pragi Patel(University of Arkansas for Medical Sciences), Ruslana G. Tytarenko(University of Arkansas for Medical Sciences), Cody Ashby(University of Arkansas for Medical Sciences), Michael Bauer(University of Arkansas for Medical Sciences), Joshua Epstein(University of Arkansas for Medical Sciences), S Deshpande(University of Arkansas for Medical Sciences), Christopher P. Wardell(University of Arkansas for Medical Sciences), Tímea Buzder(University of Arkansas for Medical Sciences), Gábor Molnár(University of Arkansas for Medical Sciences), Maurizio Zangari(University of Arkansas for Medical Sciences), Frits van Rhee(University of Arkansas for Medical Sciences), Sharmilan Thanendrarajan(University of Arkansas for Medical Sciences), Carolina Schinke(University of Arkansas for Medical Sciences), Joshua Epstein(University of Arkansas for Medical Sciences), Faith E. Davies(University of Arkansas for Medical Sciences), Brian A. Walker(University of Arkansas for Medical Sciences), Tobias Meißner(Avera Health), Bart Barlogie(University of Arkansas for Medical Sciences), Gareth J. Morgan(University of Arkansas for Medical Sciences), Niels Weinhold(University of Arkansas for Medical Sciences)
Nature Communications
August 8, 2017
Cited by 417Open Access
Full Text

Abstract

Abstract In multiple myeloma malignant plasma cells expand within the bone marrow. Since this site is well-perfused, a rapid dissemination of “fitter” clones may be anticipated. However, an imbalanced distribution of multiple myeloma is frequently observed in medical imaging. Here, we perform multi-region sequencing, including iliac crest and radiology-guided focal lesion specimens from 51 patients to gain insight into the spatial clonal architecture. We demonstrate spatial genomic heterogeneity in more than 75% of patients, including inactivation of CDKN2C and TP53 , and mutations affecting mitogen-activated protein kinase genes. We show that the extent of spatial heterogeneity is positively associated with the size of biopsied focal lesions consistent with regional outgrowth of advanced clones. The results support a model for multiple myeloma progression with clonal sweeps in the early phase and regional evolution in advanced disease. We suggest that multi-region investigations are critical to understanding intra-patient heterogeneity and the evolutionary processes in multiple myeloma.


Related Papers

No related papers found

Powered by citation graph analysis